APA (7th ed.) Citation

Harada, K., Morita-Fujita, M., Fukuda, T., Ozawa, Y., Doki, N., Toyosaki, M., . . . Arai, Y. (2022). Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Cytotherapy (Oxford, England), 24(9), 954-961. https://doi.org/10.1016/j.jcyt.2022.03.004

Chicago Style (17th ed.) Citation

Harada, Kaito, et al. "Overcoming Minimal Residual Disease Using Intensified Conditioning with Medium-dose Etoposide, Cyclophosphamide and Total Body Irradiation in Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia in Adults." Cytotherapy (Oxford, England) 24, no. 9 (2022): 954-961. https://doi.org/10.1016/j.jcyt.2022.03.004.

MLA (9th ed.) Citation

Harada, Kaito, et al. "Overcoming Minimal Residual Disease Using Intensified Conditioning with Medium-dose Etoposide, Cyclophosphamide and Total Body Irradiation in Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia in Adults." Cytotherapy (Oxford, England), vol. 24, no. 9, 2022, pp. 954-961, https://doi.org/10.1016/j.jcyt.2022.03.004.